Skip to content

Clinical trials

Observational Cardiovascular Diseases trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cardiovascular Diseases Phase: Observational Country / region: France Clear all

79 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20072
20083
20093
20103
20112
20125
20131
20153
20166
20172
20184
20198
20209
20214
20223
20234
20244
20257
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed35
Recruiting21
Unknown status9
Active, not recruiting7
Not yet recruiting3
Terminated2
Enrolling by invitation1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Assistance Publique - Hôpitaux de Paris6
University Hospital, Strasbourg, France5
French Cardiology Society4
Institut National de la Santé Et de la Recherche Médicale, France4
University Hospital, Brest3
AstraZeneca2
Boston Scientific Corporation2
Centre Hospitalier Universitaire de Nīmes2
Fondazione SISA (Societa Italiana per lo Studio della Arteriosclerosi)2
Groupe français d'étude des Maladies Inflammatoires de loeil2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cardiovascular Diseases79
Heart Diseases8
Atherosclerosis7
Vascular Diseases6
Dyslipidemias5
Arrhythmias, Cardiac4
Atrial Fibrillation4
Diabetes Mellitus4
Heart Failure4
Hypertension4

Trials

Showing 1 to 25 of 79. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.